2 employees
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.
2019
$20M
from 1 investors over 1 rounds
Immunowake, Inc. raised $20M on May 15, 2022
Investors: HEDA VENTURES